Research Submission: Plasma Cytokine Levels in Migraineurs and Controls

BackgroundThe vasoactive peptide, calcitonin gene-related peptide (CGRP), is released from primary afferent neurons in the trigemino-vascular circulation during migraine headache. CGRP at physiological concentrations and possibly via stimulation of its selective receptors on T-cells, triggers the se...

Full description

Saved in:
Bibliographic Details
Published inHeadache Vol. 45; no. 7; pp. 926 - 931
Main Authors Perini, Francesco, D'Andrea, Giovanni, Galloni, Elisabetta, Pignatelli, Francesco, Billo, Giuseppe, Alba, Sabrina, Bussone, Gennaro, Toso, Vito
Format Journal Article
LanguageEnglish
Published 01.07.2005
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundThe vasoactive peptide, calcitonin gene-related peptide (CGRP), is released from primary afferent neurons in the trigemino-vascular circulation during migraine headache. CGRP at physiological concentrations and possibly via stimulation of its selective receptors on T-cells, triggers the secretion of cytokines. Cytokines play an important role in several physiological and pathological settings such as immunology, inflammation, and pain. ObjectiveTo investigate plasma levels of pro- and anti-inflammatory cytokines in migraineurs and healthy controls. MethodsWe studied 25 migraine patients, during and outside attacks, and 18 healthy control subjects measuring plasma levels of IL-6, IL-10, tumor necrosis factor alpha (TNF alpha ), IL-4, IL-1 beta , and IL-2 using ELISA. ResultsCirculating levels of IL-10, TNF alpha , and IL-1 beta during attacks were significantly higher in comparison to their levels outside attacks (P= .0003, P= .03, and P= .05, respectively). IL-10 and TNF serum levels were higher in patients studied soon after headache onset and lower over time (P= .004 and P= .05). ConclusionOur results suggest that TNF alpha , IL-1 beta , and IL-10 may be involved in the pathogenesis of migraine attacks.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:0017-8748
1526-4610
DOI:10.1111/j.1526-4610.2005.05135.x